Phillips Adam T, Deiner Stacie, Mo Lin Hung, Andreopoulos Evie, Silverstein Jeffrey, Levin Matthew A
Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut.
Department of Anesthesiology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Geriatrics and Palliative Care, Icahn School of Medicine at Mount Sinai, New York, New York.
Clin Ther. 2015 Dec 1;37(12):2676-85. doi: 10.1016/j.clinthera.2015.10.005. Epub 2015 Nov 6.
Geriatric patients are more sensitive to the anesthetic effects of propofol and its adverse effects, such as hypotension, than is the general population; thus, a reduced dose (1-1.5 mg/kg) is recommended for the induction of anesthesia. The extent to which clinicians follow established dosing guidelines has not been well described. Therefore, we investigated the prevalence of propofol overdose in the elderly population to determine whether propofol overdose occurs and is associated with increased hypotension and 30-day mortality.
In this retrospective study in patients who received propofol for the induction of general anesthesia, data on demographic characteristics, preoperative medications, intraoperative management, and 30-day mortality were collected. The dose of propofol used for the induction of anesthesia and the median blood pressure in the pre- and immediate postinduction periods were determined. Hypotension was defined as either: (1) a decrease in mean arterial pressure (MAP) of >40% concurrent with a MAP of <70 mm Hg; or (2) a MAP of <60 mm Hg.
A total of 17,540 patients were included in the analysis; 4033 (23.0%) were aged >65 years. The median (interquartile range) propofol dose in the group aged >65 years was 1.8 (1.4-2.2) mg/kg, above the recommended dose, in comparison to 2.2 (1.9-2.5) mg/kg in younger patients. On multivariate analysis, increased propofol dose was associated with increased postinduction hypotension, especially in patients over 70 years of age, but not 30-day mortality.
Older patients received greater-than-recommended doses of propofol for induction, which may have led to significant dose-dependent hypotension. Despite this finding, the dose of propofol for induction was not independently associated with a greater 30-day mortality rate. More education regarding geriatric concerns is needed for encouraging anesthesiologists to tailor the plan for anesthesia in geriatric patients. However, overall postsurgical mortality is a function of preoperative risk and type surgical procedure.
老年患者对丙泊酚的麻醉效果及其不良反应(如低血压)比普通人群更为敏感;因此,推荐使用较低剂量(1 - 1.5毫克/千克)进行麻醉诱导。临床医生遵循既定给药指南的程度尚未得到充分描述。因此,我们调查了老年人群中丙泊酚过量的发生率,以确定丙泊酚过量是否发生及其是否与低血压增加和30天死亡率相关。
在这项针对接受丙泊酚进行全身麻醉诱导的患者的回顾性研究中,收集了有关人口统计学特征、术前用药、术中管理和30天死亡率的数据。确定了用于麻醉诱导的丙泊酚剂量以及诱导前和诱导后即刻的平均血压中位数。低血压定义为:(1)平均动脉压(MAP)下降>40%且MAP<70毫米汞柱;或(2)MAP<60毫米汞柱。
共有17540名患者纳入分析;4033名(23.0%)年龄>65岁。65岁以上组丙泊酚剂量中位数(四分位间距)为1.8(1.4 - 2.2)毫克/千克,高于推荐剂量,而年轻患者为2.2(1.9 - 2.5)毫克/千克。多因素分析显示,丙泊酚剂量增加与诱导后低血压增加相关,尤其是70岁以上患者,但与30天死亡率无关。
老年患者诱导时接受的丙泊酚剂量高于推荐剂量,这可能导致显著的剂量依赖性低血压。尽管有这一发现,但诱导时丙泊酚剂量与30天死亡率升高并无独立关联。需要对老年相关问题进行更多教育,以鼓励麻醉医生为老年患者量身定制麻醉方案。然而,总体术后死亡率是术前风险和手术类型的函数。